Supreme Court To Hear Elan/Dura Shareholder Lawsuit On Securities Fraud Standards
This article was originally published in The Pink Sheet Daily
Executive Summary
Dura is asking the high court to consider whether shareholders must show a link between allegedly misleading statements and an actual drop in stock value, or just an inflated stock price on the date of purchase. The case stems from Dura’s 1997 statements about Ceclor CD and the Spiros albuterol device.